Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,302 warrant series at 1,050 companies. 778 in the money, 59 expiring in the next 30 days, 37 waiting on a stockholder vote or other stated condition, 4 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| July 2026 acceleration Note Warrants (Asymmetry Point, 41,667) | $3.80 | $2.1M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| July 2026 additional acceleration warrant (1,500) | $3.80 | $2.1M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| July 31, 2025 subscription warrants ($4.25) | $3.80 | $2.1M | 10-K, Mar 31, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| March 1, 2024 placement agent warrants (Alere, $4.00) | $3.80 | $2.1M | 10-K, Mar 31, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| March 1, 2024 private placement investor warrants ($4.00) | $3.80 | $2.1M | 10-K, Mar 31, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| NexGelRx transaction warrants ($4.00, December 2025) | $3.80 | $2.1M | 10-K, Mar 31, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Note Warrants – April/May 2026 convertible note private placements and Celularity Note (aggregate) | $3.80 | $2.1M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| November 10, 2026 New Capital Financing (PIPE) warrants ($10.00) | $3.80 | $2.1M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| November 20, 2024 placement agent warrants (Alere, $4.25) | $3.80 | $2.1M | 10-K, Mar 31, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| November 20, 2024 private placement investor warrants ($4.25) | $3.80 | $2.1M | 10-K, Mar 31, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| November 2026 Alere placement agent warrants (New Capital Financing) | $3.80 | $2.1M | 8-K, Nov 12, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Pre-2024 warrants (outstanding at January 1, 2024, corrected; incl. December 27, 2021 IPO unit warrants (NXGLW) and 2019–2021 financing warrants) | $3.80 | $2.1M | 10-K, Mar 31, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| May 2026 Common Warrants (Private Placement) | $0.1960 | $2.1M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| ATIS Representative's Warrants (April 11, 2025 uplisting offering) | $1.72 | $2.0M | 8-K EX-4.1, Apr 11, 2025Dilution tabAs of Nov 4, 2026 | ||||||||
| June 2026 Common Warrants (offering of June 17, 2026) | $1.72 | $2.0M | 10-K, Nov 4, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| Maxim Placement Agent Warrants (June 2026 offering) | $1.72 | $2.0M | 10-K, Nov 4, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| IPO placement agent's (representative's) warrants – EF Hutton | $0.6660 | $2.0M | S-1, Oct 23, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| October 2025 private placement unit warrants | $0.6660 | $2.0M | 10-K, Mar 31, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| Publicly traded warrants (ONFOW) issued in August 2022 IPO | $0.6660 | $2.0M | S-1, Oct 23, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| Representative's Warrants (D. Boral Capital, August 2025 public offering) | $1.88 | $2.0M | 10-K, Sep 25, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series C Preferred Stock Warrant (Hexstone Capital) | $1.88 | $2.0M | S-1, Oct 5, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Placement Agent Warrants (1/10/2025) | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Placement Agent Warrants (10/24/2024) | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Placement Agent Warrants (11/15/2024) | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Placement Agent Warrants (3/31/2025) | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Placement Agent Warrants (4/18/2024) | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Placement Agent Warrants (6/3/2024) | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Private Warrants | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Public Warrants | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Representative Warrants (8/21/2025) | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series A Warrants | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series B-1 Warrants | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series C-1 Warrants (6/3/2024) | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series C-1 Warrants (8/16/2024) | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series C-1 Warrants (8/8/2024) | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series D Warrants | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series G Warrants | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series H Warrants | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series I Warrants | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series J Warrants | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series K Warrants | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Underwriter Warrants (3/9/2026) | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Warrants to purchase Restricted Shares (2/21/2024) | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Warrants to purchase Restricted Shares (7/28/2024) | $0.5597 | $1.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Aug 9–Sep 30, 2024 convertible note warrants ($17.50) | $0.1685 | $1.9M | S-1, Oct 27, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| July 31, 2025 Board-granted warrants (directors, officers, employees) – remaining former-employee holders | $0.1685 | $1.9M | 10-K, Apr 15, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| May 1, 2024 SPA warrants ($34.00) – Cavalry/WVP/A.W. Jones | $0.1685 | $1.9M | 10-K, Apr 15, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Sept 29, 2023 note warrants – Cavalry/WVP/A.W. Jones | $0.1685 | $1.9M | 424B3, Nov 4, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series A-1 Class A one-year warrants (80% of 5-day VWAP) | $0.1685 | $1.9M | S-1, Oct 27, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series A-1 Class B five-year warrants ($4.00) | $0.1685 | $1.9M | S-1, Oct 27, 2026Dilution tabAs of Nov 12, 2026 |
NXGLNEXGEL, Inc.$3.80Last price
July 2026 acceleration Note Warrants (Asymmetry Point, 41,667)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.1M
NXGLNEXGEL, Inc.$3.80Last price
July 2026 additional acceleration warrant (1,500)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.1M
NXGLNEXGEL, Inc.$3.80Last price
July 31, 2025 subscription warrants ($4.25)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.1M
NXGLNEXGEL, Inc.$3.80Last price
March 1, 2024 placement agent warrants (Alere, $4.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.1M
NXGLNEXGEL, Inc.$3.80Last price
March 1, 2024 private placement investor warrants ($4.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.1M
NXGLNEXGEL, Inc.$3.80Last price
NexGelRx transaction warrants ($4.00, December 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.1M
NXGLNEXGEL, Inc.$3.80Last price
Note Warrants – April/May 2026 convertible note private placements and Celularity Note (aggregate)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.1M
NXGLNEXGEL, Inc.$3.80Last price
November 10, 2026 New Capital Financing (PIPE) warrants ($10.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.1M
NXGLNEXGEL, Inc.$3.80Last price
November 20, 2024 placement agent warrants (Alere, $4.25)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.1M
NXGLNEXGEL, Inc.$3.80Last price
November 20, 2024 private placement investor warrants ($4.25)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.1M
NXGLNEXGEL, Inc.$3.80Last price
November 2026 Alere placement agent warrants (New Capital Financing)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.1M
NXGLNEXGEL, Inc.$3.80Last price
Pre-2024 warrants (outstanding at January 1, 2024, corrected; incl. December 27, 2021 IPO unit warrants (NXGLW) and 2019–2021 financing warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.1M
CODXCo-Diagnostics, Inc.$0.1960Last price
May 2026 Common Warrants (Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.1M
CIITTianci International, Inc. Common Stock$1.72Last price
ATIS Representative's Warrants (April 11, 2025 uplisting offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.0M
CIITTianci International, Inc. Common Stock$1.72Last price
June 2026 Common Warrants (offering of June 17, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.0M
CIITTianci International, Inc. Common Stock$1.72Last price
Maxim Placement Agent Warrants (June 2026 offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.0M
ONFOOnfolio Holdings, Inc.$0.6660Last price
IPO placement agent's (representative's) warrants – EF Hutton
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.0M
ONFOOnfolio Holdings, Inc.$0.6660Last price
October 2025 private placement unit warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.0M
ONFOOnfolio Holdings, Inc.$0.6660Last price
Publicly traded warrants (ONFOW) issued in August 2022 IPO
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.0M
PPCBPropanc Biopharma, Inc. Common Stock$1.88Last price
Representative's Warrants (D. Boral Capital, August 2025 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.0M
PPCBPropanc Biopharma, Inc. Common Stock$1.88Last price
Series C Preferred Stock Warrant (Hexstone Capital)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.0M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Placement Agent Warrants (1/10/2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Placement Agent Warrants (10/24/2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Placement Agent Warrants (11/15/2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Placement Agent Warrants (3/31/2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Placement Agent Warrants (4/18/2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Placement Agent Warrants (6/3/2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Private Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Public Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Representative Warrants (8/21/2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Series A Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Series B-1 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Series C-1 Warrants (6/3/2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Series C-1 Warrants (8/16/2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Series C-1 Warrants (8/8/2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Series D Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Series G Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Series H Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Series I Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Series J Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Series K Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Underwriter Warrants (3/9/2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Warrants to purchase Restricted Shares (2/21/2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
CLDICalidi Biotherapeutics, Inc.$0.5597Last price
Warrants to purchase Restricted Shares (7/28/2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
EDVAEndovia Health Sciences, Inc.$0.1685Last price
Aug 9–Sep 30, 2024 convertible note warrants ($17.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
EDVAEndovia Health Sciences, Inc.$0.1685Last price
July 31, 2025 Board-granted warrants (directors, officers, employees) – remaining former-employee holders
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
EDVAEndovia Health Sciences, Inc.$0.1685Last price
May 1, 2024 SPA warrants ($34.00) – Cavalry/WVP/A.W. Jones
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
EDVAEndovia Health Sciences, Inc.$0.1685Last price
Sept 29, 2023 note warrants – Cavalry/WVP/A.W. Jones
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
EDVAEndovia Health Sciences, Inc.$0.1685Last price
Series A-1 Class A one-year warrants (80% of 5-day VWAP)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
EDVAEndovia Health Sciences, Inc.$0.1685Last price
Series A-1 Class B five-year warrants ($4.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.9M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,062 dilution snapshots. 4,848 of 5,302 series state an exercise price and 3,366 an expiry date. 119 record when exercise begins; that count grows as companies are re-extracted. 631 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.